Substance Use Disorders (SUD)Public Health, Prevention & Behaviour Change

The Integration of Classic Psychedelics into Current Substance Use Disorder Treatment Models

This review (2023) discusses the potential integration of classic psychedelic-assisted therapies (PAT) into current clinical practices for substance use disorders (SUDs). With promising results from initial studies, the authors suggest that classic psychedelic-assisted therapies could become legally available options for SUD patients in the future. The article outlines contemporary evidence-based treatments for SUDs and proposes that classic psychedelic-assisted therapies can be broadly compatible with existing mainstream SUD treatment paradigms, offering a new avenue for exploration in addressing these disorders.

Ask Blossom about this paper

Authors

  • Albert Garcia-Romeu
  • Peter Hendricks
  • Matthew Johnson

Published

Pharmacological Research
meta Study

Abstract

Substance use disorders (SUDs) have an enormous impact on public health. With classic psychedelic-assisted therapies showing initial promise in treating multiple SUDs, it is possible that these treatments will become legally available options for patients with SUDs in the future. This article highlights how classic psychedelic-assisted therapies might be integrated into current clinical practice. We first describe contemporary evidence-based treatments for SUDs and highlight how classic psychedelic-assisted therapies might fit within each treatment. We suggest that classic psychedelic-assisted therapies can be integrated into most mainstream evidence-based SUD treatments that are currently used in clinical settings, indicating broad compatibility of classic psychedelics with contemporary SUD treatment paradigms.

Unlocked with Blossom Pro

Research Summary of 'The Integration of Classic Psychedelics into Current Substance Use Disorder Treatment Models'

Editorial

βBlossom's Take

This review is useful because it places classic psychedelic-assisted therapy beside existing substance use disorder treatments instead of treating it as a separate or exceptional pathway. It is a framing paper rather than an efficacy paper, but that is exactly its value, it clarifies where psychedelics might fit in mainstream care and where compatibility still needs evidence.

Study Details

The Integration of Classic Psychedelics into... — Research Summary & Context | Blossom